Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease

Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease

BackgroundSleep disturbances are commonly encountered in people with advanced Parkinson's disease (PD). In these stages, levodopa–carbidopa intestinal gel (LCIG) is recommended for improving motor symptoms, some non-motor dysfunctions, and quality of life in these patients. This study aimed to...

Full description

Bibliographic Details
Main Authors:	Ştefania Diaconu, Laura Irincu, Diana Ţînţ, Cristian Falup-Pecurariu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Neurology
Subjects:	intrajejunal levodopa infusion sleep insomnia advanced Parkinson's disease longitudinal
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1105650/full

Similar Items

Intrajejunal Infusion of Levodopa-Carbidopa Gel Can Continuously Reduce the Severity of Dropped Head in Parkinson’s Disease
by: Hiroshi Kataoka, et al.
Published: (2017-10-01)

Nocturia and Sleep in Parkinson’s Disease
by: Ştefania Diaconu, et al.
Published: (2023-06-01)

Restless Legs Syndrome in Parkinson’s Disease
by: Ştefania Diaconu, et al.
Published: (2023-05-01)

Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson’s Disease
by: Ştefania Diaconu, et al.
Published: (2022-02-01)

Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson’s disease - the INfusion VErsus STimulation (INVEST) study
by: D. van Poppelen, et al.
Published: (2020-01-01)

Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
by: Daniël van Poppelen, et al.
Published: (2021-06-01)

Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report
by: Vinod Metta, et al.
Published: (2022-09-01)

Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors
by: Vinod Metta, et al.
Published: (2021-07-01)

Dry eye in Parkinson's disease: a narrative review
by: Larisa Ungureanu, et al.
Published: (2023-08-01)

Diplopia in Movement Disorders: A Systematic Review of the Literature
by: Larisa Ungureanu, et al.
Published: (2024-02-01)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
by: Angelo Antonini
Published: (2009-05-01)

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel
by: K. Amande M. Pauls, et al.
Published: (2021-12-01)

PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
by: Simone Simoni, et al.
Published: (2022-01-01)

Continuous intestinal infusion of levodopa–carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community
by: D. Santos-García, et al.
Published: (2021-03-01)

An updated calculator for determining levodopa-equivalent dose
by: D. Nyholm, et al.
Published: (2021-10-01)

Levodopa-Carbidopa Intestinal Gel may improve treatment-resistant freezing of gait in Parkinson’s disease
by: Melanie R. Shackleford, et al.
Published: (2022-01-01)

Uso de la infusión intestinal continua de levodopa-carbidopa en pacientes con enfermedad de Parkinson avanzada en España. Subanálisis por comunidades autónomas
by: D. Santos-García, et al.
Published: (2021-03-01)

Sleep disturbances in drug naïve Parkinson′s disease (PD) patients and effect of levodopa on sleep
by: Teresa Ferreira, et al.
Published: (2014-01-01)

Levodopa for treatment of parkinson’s disease
by: M. Petraru, et al.
Published: (2011-09-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice
by: Mezin Öthman, et al.
Published: (2021-03-01)

Levodopa-carbidopa intestinal gel therapy may cause “Supra-ON freezing of gate” in patients with Parkinson's disease with diphasic dyskinesia
by: Saki Oshiro, et al.
Published: (2021-12-01)

Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis
by: Xiao Dong Liu, et al.
Published: (2019-08-01)

Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance
by: Victor S.C. Fung, et al.
Published: (2024-01-01)

Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test
by: Xiaoqin He, et al.
Published: (2022-01-01)

Dynamics of levodopa-therapy in patients with Parkinson’s disease afterunilateral pallidotomy
by: V.I. Tsymbaliuk, et al.
Published: (2018-12-01)

Investigation of <i>PRKN</i> Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
by: Ana Gabrielle Bispo, et al.
Published: (2023-08-01)

Prosody and levodopa in Parkinsons disease
by: Luciana Lemos de Azevedo, et al.
Published: (2013-11-01)

Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01)

Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
by: Kye Won Park, et al.
Published: (2020-09-01)

Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism
by: Masatoshi Ogawa, et al.
Published: (2019-12-01)

Levodopa-Responsive Benign Tremulous Parkinsonism
by: Osamu Kano, et al.
Published: (2013-08-01)

Thrombocytopenia Associated with Levodopa Treatment
by: Ku-Eun Lee, et al.
Published: (2013-05-01)

Complications of percutaneous endoscopic gastrostomy-jejunostomy for levodopa/carbidopa infusion in advanced Parkinson's disease
by: Ana Olivares, et al.
Published: (2012-03-01)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
by: Modugno N, et al.
Published: (2020-12-01)

A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson’s disease
by: Debleena Guin, et al.
Published: (2017-09-01)

The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel
by: Pedersen SW, et al.
Published: (2017-01-01)

Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
by: Sanju P Joy, et al.
Published: (2015-01-01)

Close relationships in Parkinson´s disease patients with device‐aided therapy
by: Monica Scharfenort, et al.
Published: (2021-06-01)

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence
by: Ritam Bandopadhyay, et al.
Published: (2022-04-01)